Therefore, IL-6 can affect the stability of PD-L1 and its binding to PD-1 on immune cells through the IL-6/JAK1/STAT3 pathway, thereby mediating the immune escape of tumor cells (48). This evidence concerns the gene JAK1 and neoplasm.